186 related articles for article (PubMed ID: 30016829)
21. Clinical significance of a second-line chemotherapy regimen with paclitaxel, ifosfamide and nedaplatin for metastatic urothelial carcinoma after failure of cisplatin-based chemotherapy.
Kobayashi K; Matsuyama H; Shimizu K; Fujii N; Inoue R; Yamamoto Y; Matsumoto H; Nagao K
Jpn J Clin Oncol; 2016 Aug; 46(8):775-80. PubMed ID: 27272172
[TBL] [Abstract][Full Text] [Related]
22. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors.
Einhorn LH; Williams SD; Chamness A; Brames MJ; Perkins SM; Abonour R
N Engl J Med; 2007 Jul; 357(4):340-8. PubMed ID: 17652649
[TBL] [Abstract][Full Text] [Related]
23. Current trends in chemotherapy for metastatic nonseminomatous testicular germ cell tumors.
Bokemeyer C
Oncology; 1998; 55(3):177-88. PubMed ID: 9560052
[TBL] [Abstract][Full Text] [Related]
24. Treatment of testicular cancer: a new and improved model.
Einhorn LH
J Clin Oncol; 1990 Nov; 8(11):1777-81. PubMed ID: 1700077
[TBL] [Abstract][Full Text] [Related]
25. Irinotecan and nedaplatin as salvage therapy for patients with advanced germ cell tumors following intensive treatment with cisplatin-based combination chemotherapies.
Nishikawa M; Miyake H; Fujisawa M
Int J Clin Oncol; 2016 Feb; 21(1):162-7. PubMed ID: 26123313
[TBL] [Abstract][Full Text] [Related]
26. Long-term results of first-line sequential high-dose carboplatin, etoposide and ifosfamide chemotherapy with peripheral blood stem cell support for patients with advanced testicular germ cell tumor.
Miki T; Mizutani Y; Akaza H; Ozono S; Tsukamoto T; Terachi T; Naito K; Nonomura N; Hara I; Yoshida O;
Int J Urol; 2007 Jan; 14(1):54-9. PubMed ID: 17199861
[TBL] [Abstract][Full Text] [Related]
27. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological characteristics and oncological outcomes in patients with renal cell carcinoma registered in 2007: The first large-scale multicenter study from the Cancer Registration Committee of the Japanese Urological Association.
Kanayama HO; Fukumori T; Fujimoto H; Nakanishi H; Ohyama C; Suzuki K; Nishiyama H; Eto M; Miki T; Kamoi K; Kubota Y; Takahashi S; Homma Y; Naito S
Int J Urol; 2015 Sep; 22(9):S1-7. PubMed ID: 26332059
[TBL] [Abstract][Full Text] [Related]
29. High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA).
Haugnes HS; Laurell A; Stierner U; Bremnes RM; Dahl O; Cavallin-Ståhl E; Cohn-Cedermark G
Acta Oncol; 2012 Feb; 51(2):168-76. PubMed ID: 22175254
[TBL] [Abstract][Full Text] [Related]
30. Disease Characteristics and Treatment Outcome of Testicular Germ Cell Tumors Treated with Platinum-Based Regimens.
Sattar A; Masood M; Nisar H; Fatima I; Shahid AB
J Coll Physicians Surg Pak; 2018 Apr; 28(4):292-296. PubMed ID: 29615170
[TBL] [Abstract][Full Text] [Related]
31. Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer.
Motzer RJ; Sheinfeld J; Mazumdar M; Bains M; Mariani T; Bacik J; Bajorin D; Bosl GJ
J Clin Oncol; 2000 Jun; 18(12):2413-8. PubMed ID: 10856101
[TBL] [Abstract][Full Text] [Related]
32. Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival.
McCaffrey JA; Mazumdar M; Bajorin DF; Bosl GJ; Vlamis V; Motzer RJ
J Clin Oncol; 1997 Jul; 15(7):2559-63. PubMed ID: 9215825
[TBL] [Abstract][Full Text] [Related]
33. Impact of multimodal treatment on prognosis for patients with metastatic upper urinary tract urothelial cancer: Subanalysis of the multi-institutional nationwide case series study of the Japanese Urological Association.
Inokuchi J; Naito S; Fujimoto H; Hara T; Sakura M; Nishiyama H; Miyazaki J; Kikuchi E; Hinotsu S; Koie T; Ohyama C;
Int J Urol; 2016 Mar; 23(3):224-30. PubMed ID: 26659912
[TBL] [Abstract][Full Text] [Related]
34. Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminomatous testicular cancer.
de Wit R; Sylvester R; Tsitsa C; de Mulder PH; Sleyfer DT; ten Bokkel Huinink WW; Kaye SB; van Oosterom AT; Boven E; Vermeylen K; Stoter G
Br J Cancer; 1997; 75(3):432-5. PubMed ID: 9020492
[TBL] [Abstract][Full Text] [Related]
35. Lowered Cisplatin Dose and No Bleomycin in the Treatment of Pediatric Germ Cell Tumors: Results of the GCT-99 Protocol From the Brazilian Germ Cell Pediatric Oncology Cooperative Group.
Lopes LF; Macedo CR; Aguiar Sdos S; Barreto JH; Martins GE; Sonaglio V; Milone M; Lima ER; Almeida MT; Lopes PM; Watanabe FM; D'Andrea ML; Pianovski MA; Melaragno R; Vianna SM; Moreira ME; Bruniera P; de Oliveira CZ
J Clin Oncol; 2016 Feb; 34(6):603-10. PubMed ID: 26729441
[TBL] [Abstract][Full Text] [Related]
36. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
Schmidt P; Haas RJ; Göbel U; Calaminus G
Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897
[TBL] [Abstract][Full Text] [Related]
37. [Testicular cancer--is there an indication for adjuvant or neoadjuvant systemic therapy?].
Langenkamp S; Albers P
Urologe A; 2007 Oct; 46(10):1389-90, 1392-4. PubMed ID: 17874229
[TBL] [Abstract][Full Text] [Related]
38. Cisplatin containing combination chemotherapy of advanced germ cell line testicular tumours.
Bodrogi I; Baki M; Horti J; Géczi L; Liszka G; Ottó S; Hindy I; Eckhardt S; Sugár J
Acta Med Hung; 1994; 50(3-4):275-92. PubMed ID: 8587840
[TBL] [Abstract][Full Text] [Related]
39. Salvage chemotherapy with methotrexate, etoposide and actinomycin D in men with metastatic nonseminomatous germ cell tumors with a choriocarcinoma component: a preliminary report.
Terakawa T; Miyake H; Muramaki M; Takenaka A; Fujisawa M
Int J Urol; 2010 Oct; 17(10):881-5. PubMed ID: 20731738
[TBL] [Abstract][Full Text] [Related]
40. [Long-term results of multimodality therapy of testicular germ cell tumor].
Wang JW; Yang L; Wang JY; Qu T; Cai RG; Huang J; Sun Y
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):382-5. PubMed ID: 12921572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]